Could this vitamin A derivative cure liver cancer?

By EASL May 02,2018
A new study reveals how a derivative of vitamin A called acyclic retinoid could help to eradicate the most common form of liver cancer: hepatocellular carcinoma. Researchers shed light on how a synthetic form of vitamin A could help to eradicate liver cancer. Led by researchers from the RIKEN Center for Integrative Medical Sciences in Japan, the study found that acyclic retinoid blocks the expression of a gene that gives rise to liver cancer tumors.

To read the full article, visit: MedicalNewsToday